<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-117999</identifier>
<setSpec>1889-1837</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Profile of co-morbidity, control level, health care resources use and of cardiovascular event presence in subjects with arterial hypertension in a health primary care setting</dc:title>
<dc:description xml:lang="en">Objective: Todeterminecomorbidity,degreeofcontrolandcostsaccordingtothepresence/absence ofcardiovascularevents(CVE)inprimaryhealthcare(PHC)patientswith hypertension(HT).Patients andmethods: A retrospectivemulticenterstudy.Patientsaged 430 yearsfromfive PHCteamswereincludedin2006.Comparativecohort:generalpopulation.Mainmeasures: CVE,CharlsonComorbidityIndex(severity),comorbidity(AdjustedClinicalGroups), clinicalparameters(bloodpressure,lipids,glycemia,etc.)anddegreeofcontrol.Optimal control(o140/90, and r130/80mmHgindiabeticsandpatientswithCVE)andmoderate control(r140/90 mmHg)wasestablishedaccordingtoNCEP-ATPIIIcriteria.Amodel ofdirectcostswasestablished,differentiatingbetweenfixedandvariable(drugs,tests andreferrals)costs.ModelswerecorrectedusinglogisticregressionanalysisandANCOVAtests,withalevelofsignificancepo0.05.Results: In total57,025patientswereincluded,ofwhom26.5%(95%confidenceintervals,[CI]: 25.8&#150;27.2%) hadHT.Hypertensiveshadahigherage(67.6vs.49.5years),proportionof women(56.9%vs.54.0%),generalmorbidity(7.1vs.4.2episodes/year)andCharlsonComorbidity Index(0.9%vs.0.3%),po0,001. HTwasindependentlyassociatedwithobesity(OR &amp;#188; 2.9), diabetes(OR &amp;#188; 2.1), dyslipidemia(OR &amp;#188; 1.9), CVE(OR &amp;#188; 1.3) andage(OR &amp;#188; 1.1). Optimalcontrolwasobservedin52%ofpatients(56.0%withoutCVEand35.1% withCVE,po0.001). Themeanunitcostwas457.90eurosinthegeneralpopulation,1,171.80 eurosinpatientswithHTand1,757.09eurosinpatientswithCVE.Theadjustedmean unitcost(ANCOVA)was565.29euros,870.21h and 1,504.35euros,respectively,po0,001. Thesedifferencesweremaintainedforallcostcomponents.Conclusions: Optimal controlcanstillbeimproved.PatientswithHTconsumealargeamount ofhealthresources.HTshouldbeconsideredtogetherwithothercardiovascularrisk factors(AU)</dc:description>
<dc:creator>Velasco-Velasco, S</dc:creator>
<dc:creator>Navarro-Artieda, R</dc:creator>
<dc:creator>Sicras-Mainar, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">ConclusionesEl control 칩ptimo sigue siendo mejorable. Los pacientes con HTA presentan un elevado consumo de recursos. Se debe considerar la HTA en conjunto con otros factores de riesgo cardiovascular(AU)</dc:description>
<dc:source>Hipertens. riesgo vasc;26(5): 201-212, sep.-oct. 2009. tab, graf</dc:source>
<dc:identifier>ibc-117999</dc:identifier>
<dc:title xml:lang="es">Perfil de comorbilidad, grado de control, uso de recursos sanitarios y presencia de evento cardiovascular en sujetos con hipertensi칩n arterial en el 치mbito de la atenci칩n primaria de salud</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7152^s22080</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d30769</dc:subject>
<dc:subject>^d11756</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:type>article</dc:type>
<dc:date>200910</dc:date>
</metadata>
</record>
</ibecs-document>
